176 related articles for article (PubMed ID: 27609361)
1. Aging-Related Decline of Glutathione Peroxidase 3 and Risk of Cardiovascular Events in Patients With Atrial Fibrillation.
Pastori D; Pignatelli P; Farcomeni A; Menichelli D; Nocella C; Carnevale R; Violi F
J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27609361
[TBL] [Abstract][Full Text] [Related]
2. Is There an Interplay Between Adherence to Mediterranean Diet, Antioxidant Status, and Vascular Disease in Atrial Fibrillation Patients?
Pastori D; Carnevale R; Menichelli D; Nocella C; Bartimoccia S; Novo M; Leo I; Violi F; Pignatelli P
Antioxid Redox Signal; 2016 Nov; 25(14):751-755. PubMed ID: 27577528
[TBL] [Abstract][Full Text] [Related]
3. Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation.
Pastori D; Pignatelli P; Farcomeni A; Cangemi R; Hiatt WR; Bartimoccia S; Nocella C; Vicario T; Bucci T; Carnevale R; Lip GY; Violi F
Am Heart J; 2015 Sep; 170(3):490-7.e1. PubMed ID: 26385032
[TBL] [Abstract][Full Text] [Related]
4. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events.
Eikelboom JW; Hirsh J; Weitz JI; Johnston M; Yi Q; Yusuf S
Circulation; 2002 Apr; 105(14):1650-5. PubMed ID: 11940542
[TBL] [Abstract][Full Text] [Related]
5. Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation.
Pastori D; Nocella C; Farcomeni A; Bartimoccia S; Santulli M; Vasaturo F; Carnevale R; Menichelli D; Violi F; Pignatelli P;
J Am Coll Cardiol; 2017 Sep; 70(12):1455-1462. PubMed ID: 28911508
[TBL] [Abstract][Full Text] [Related]
6. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease.
Blankenberg S; Rupprecht HJ; Bickel C; Torzewski M; Hafner G; Tiret L; Smieja M; Cambien F; Meyer J; Lackner KJ;
N Engl J Med; 2003 Oct; 349(17):1605-13. PubMed ID: 14573732
[TBL] [Abstract][Full Text] [Related]
7. Mediterranean diet reduces thromboxane A2 production in atrial fibrillation patients.
Pignatelli P; Pastori D; Farcomeni A; Nocella C; Bartimoccia S; Vicario T; Bucci T; Carnevale R; Violi F
Clin Nutr; 2015 Oct; 34(5):899-903. PubMed ID: 25288566
[TBL] [Abstract][Full Text] [Related]
8. Circulating Lipopolysaccharides and Impaired Antioxidant Status in Patients With Atrial Fibrillation. Data From the ATHERO-AF Study.
Menichelli D; Carnevale R; Nocella C; Cammisotto V; Castellani V; Bartimoccia S; Frati G; Pignatelli P; Pastori D
Front Cardiovasc Med; 2021; 8():779503. PubMed ID: 34869693
[No Abstract] [Full Text] [Related]
9. Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors.
Pastori D; Pignatelli P; Angelico F; Farcomeni A; Del Ben M; Vicario T; Bucci T; Raparelli V; Cangemi R; Tanzilli G; Lip GYH; Violi F
Chest; 2015 Jun; 147(6):1644-1650. PubMed ID: 25429521
[TBL] [Abstract][Full Text] [Related]
10. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
[TBL] [Abstract][Full Text] [Related]
11. Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk.
Eikelboom JW; Hankey GJ; Thom J; Bhatt DL; Steg PG; Montalescot G; Johnston SC; Steinhubl SR; Mak KH; Easton JD; Hamm C; Hu T; Fox KA; Topol EJ;
Circulation; 2008 Oct; 118(17):1705-12. PubMed ID: 18838564
[TBL] [Abstract][Full Text] [Related]
12. Association of Brachial-Ankle Pulse Wave Velocity With Cardiovascular Events in Atrial Fibrillation.
Chen SC; Lee WH; Hsu PC; Lin MY; Lee CS; Lin TH; Voon WC; Lai WT; Sheu SH; Su HM
Am J Hypertens; 2016 Mar; 29(3):348-56. PubMed ID: 26271108
[TBL] [Abstract][Full Text] [Related]
13. Diagnosed Sleep Apnea and Cardiovascular Disease in Atrial Fibrillation Patients: The Role of Measurement Error from Administrative Data.
Ogilvie RP; MacLehose RF; Alonso A; Norby FL; Lakshminarayan K; Iber C; Chen LY; Lutsey PL
Epidemiology; 2019 Nov; 30(6):885-892. PubMed ID: 31205284
[TBL] [Abstract][Full Text] [Related]
14. Age-related increase of thromboxane B2 and risk of cardiovascular disease in atrial fibrillation.
Pastori D; Pignatelli P; Farcomeni A; Nocella C; Bartimoccia S; Carnevale R; Violi F
Oncotarget; 2016 Jun; 7(26):39143-39147. PubMed ID: 27270651
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular Events after New-Onset Atrial Fibrillation in Adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) Study.
Bansal N; Xie D; Sha D; Appel LJ; Deo R; Feldman HI; He J; Jamerson K; Kusek JW; Messe S; Navaneethan SD; Rahman M; Ricardo AC; Soliman EZ; Townsend R; Go AS
J Am Soc Nephrol; 2018 Dec; 29(12):2859-2869. PubMed ID: 30377231
[TBL] [Abstract][Full Text] [Related]
16. Urinary 11-Dehydro-Thromboxane B2 as a Predictor of Acute Myocardial Infarction Outcomes: Results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) Study.
Szczeklik W; Stodółkiewicz E; Rzeszutko M; Tomala M; Chrustowicz A; Żmudka K; Sanak M
J Am Heart Assoc; 2016 Aug; 5(8):. PubMed ID: 27481134
[TBL] [Abstract][Full Text] [Related]
17. Serum NOX2 and urinary isoprostanes predict vascular events in patients with atrial fibrillation.
Pignatelli P; Pastori D; Carnevale R; Farcomeni A; Cangemi R; Nocella C; Bartimoccia S; Vicario T; Saliola M; Lip GY; Violi F
Thromb Haemost; 2015 Mar; 113(3):617-24. PubMed ID: 25392853
[TBL] [Abstract][Full Text] [Related]
18. Glutathione peroxidase, superoxide dismutase and catalase genotypes and activities and the progression of chronic kidney disease.
Crawford A; Fassett RG; Coombes JS; Kunde DA; Ahuja KD; Robertson IK; Ball MJ; Geraghty DP
Nephrol Dial Transplant; 2011 Sep; 26(9):2806-13. PubMed ID: 21325350
[TBL] [Abstract][Full Text] [Related]
19. Biomarker-based risk prediction in the community.
AbouEzzeddine OF; McKie PM; Scott CG; Rodeheffer RJ; Chen HH; Michael Felker G; Jaffe AS; Burnett JC; Redfield MM
Eur J Heart Fail; 2016 Nov; 18(11):1342-1350. PubMed ID: 27813304
[TBL] [Abstract][Full Text] [Related]
20. Plasma antioxidant enzymes and lipoperoxidation status in children with Down syndrome.
He J; Li T; Chen J; Liu Y; Xiong F; Yang J; Song C
Clin Biochem; 2016 Jan; 49(1-2):61-5. PubMed ID: 26340803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
